Literature DB >> 15137052

Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP).

Pamela Osenkowski1, Marta Toth, Rafael Fridman.   

Abstract

Matrix metalloproteinases (MMPs) are multidomain zinc-dependent proteolytic enzymes that play pivotal roles in many normal and pathological processes. Some members of the MMP family are anchored to the plasma membrane via specialized domains and thus are perfectly suited for pericellular proteolysis. Membrane-anchoring also confers the membrane type-MMPs (MT-MMPs) a unique and complex array of regulatory processes that endow cells with the ability to control MT-MMP-dependent proteolytic activity independently of the levels of endogenous protease inhibitors. Emerging evidence indicates that mechanisms as diverse as autocatalytic processing, ectodomain shedding, homodimerization and internalization can all contribute to the modulation of MT-MMP activity on the cell surface. How these distinct processes interact to attain the optimal level of enzyme activity in a particular setting and the molecular signals that trigger them constitute a new paradigm in MMP regulation. This review will discuss the recent findings concerning these diverse regulatory mechanisms in the context of MT1-MMP (MMP-14). Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15137052     DOI: 10.1002/jcp.20064

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  77 in total

1.  Mechanical control of spheroid growth: distinct morphogenetic regimes.

Authors:  Oswaldo A Lozoya; Sharon R Lubkin
Journal:  J Biomech       Date:  2011-12-06       Impact factor: 2.712

Review 2.  Molecular and cellular mechanisms of ectodomain shedding.

Authors:  Kazutaka Hayashida; Allison H Bartlett; Ye Chen; Pyong Woo Park
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

Review 3.  Placental membrane-type metalloproteinases (MT-MMPs): Key players in pregnancy.

Authors:  Alejandro Majali-Martinez; Ursula Hiden; Nassim Ghaffari-Tabrizi-Wizsy; Uwe Lang; Gernot Desoye; Martina Dieber-Rotheneder
Journal:  Cell Adh Migr       Date:  2016-01-08       Impact factor: 3.405

Review 4.  Probing cellular microenvironments and tissue remodeling by atomic force microscopy.

Authors:  Thomas Ludwig; Robert Kirmse; Kate Poole; Ulrich S Schwarz
Journal:  Pflugers Arch       Date:  2007-12-06       Impact factor: 3.657

5.  Formation of Pmel17 amyloid is regulated by juxtamembrane metalloproteinase cleavage, and the resulting C-terminal fragment is a substrate for gamma-secretase.

Authors:  Markus P Kummer; Hiroko Maruyama; Claudia Huelsmann; Sandra Baches; Sascha Weggen; Edward H Koo
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

6.  Biochemical evidence of the interactions of membrane type-1 matrix metalloproteinase (MT1-MMP) with adenine nucleotide translocator (ANT): potential implications linking proteolysis with energy metabolism in cancer cells.

Authors:  Ilian A Radichev; Albert G Remacle; Nor Eddine Sounni; Sergey A Shiryaev; Dmitri V Rozanov; Wenhong Zhu; Natalya V Golubkova; Tatiana I Postnova; Vladislav S Golubkov; Alex Y Strongin
Journal:  Biochem J       Date:  2009-04-28       Impact factor: 3.857

7.  MT1-MMP evaluation in neointimal hyperplasia in the late follow-up after prosthesis implantation.

Authors:  Marta Bruczko; Tomasz Gogiel; Małgorzata Wolańska; Radosław Kowalewski; Krzysztof Sobolewski; Lech Romanowicz
Journal:  Int J Exp Pathol       Date:  2019-05-06       Impact factor: 1.925

8.  The cytoplasmic tail dileucine motif LL572 determines the glycosylation pattern of membrane-type 1 matrix metalloproteinase.

Authors:  Thomas Ludwig; Sarah M Theissen; Michael J Morton; Michael J Caplan
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

9.  Characterization and regulation of MT1-MMP cell surface-associated activity.

Authors:  Sonia Pahwa; Manishabrata Bhowmick; Sabrina Amar; Jian Cao; Alex Y Strongin; Rafael Fridman; Stephen J Weiss; Gregg B Fields
Journal:  Chem Biol Drug Des       Date:  2018-12-19       Impact factor: 2.817

Review 10.  Tumour endoproteases: the cutting edge of cancer drug delivery?

Authors:  J M Atkinson; C S Siller; J H Gill
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.